trending Market Intelligence /marketintelligence/en/news-insights/trending/VxAIj9ClygJPGU6KvoAb0w2 content esgSubNav
In This List

Nuvectra to lay off up to 25% of workforce

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Nuvectra to lay off up to 25% of workforce

Nuvectra Corp. said it will lay off about 20% to 25% of its workforce during the third quarter.

Founded in 2008, the Plano, Texas-based company, which employs nearly 200 people, has failed to generate a profit since at least 2014, according to S&P Global Market Intelligence data. The decision follows an announcement from Nuvectra that it was exploring potential strategic alternatives for the business, including a sale or merger.

The lay off will cost the company around $600,000 in pretax severance and other expenses but result in net pretax operating expense savings of about $1.2 million this year and about $5.8 million annually in 2020 and beyond.

Nuvectra develops and commercializes neurostimulation technology platform for the treatment of various disorders in neuroscience and clinical markets.